A new screening test from the Irish biotech start-up Biosensia could play a significant role in the speedy diagnosis of head trauma.
Proteomics is the study of the structures and functions of proteins, and it’s currently a very hot topic in the world of molecular biology. In a nutshell, it helps scientists understand the functions of cellular systems in human disease. Researchers at Biosensia are currently using proteomics to look at how body proteins change due to an illness or to a major event such as a traumatic brain injury (TBI).
Original source of this content: http://www.irishtimes.com/business/biosensia-screening-test-set-to-speed-up-diagnosis-of-head-trauma-1.2758117